Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation
Acquired, activating mutations of MPL W515 are recognised driver mutations of the myeloproliferative neoplasms (MPN), namely, essential thrombocythemia and primary myelofibrosis. The most common mutation at this codon is W515L with several other mutations also described at a lower frequency. Of thes...
Main Authors: | Stephen E. Langabeer, Lisa Lee Tokar, Laura Kearney, Cathal O’Brien, Kowshika Thavarajah, Aisling Barrett, John McManus, Hilary O’Leary |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2020/8375986 |
Similar Items
-
Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis.
by: Giovanni Barosi, et al.
Published: (2012-01-01) -
A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis.
by: Vibe Skov, et al.
Published: (2016-01-01) -
Concomitant BCR-ABL1 positive chronic myelogenous leukemia emerging in a patient with MPL W515L associated primary myelofibrosis
by: Juan C. Gomez-Gelvez, MD, et al.
Published: (2016-03-01) -
MPL W515 L/K mutations in myeloproliferative neoplasms
by: Sohaila Eldeweny, et al.
Published: (2019-12-01) -
Immune Complex Associated Glomerulonephritis in a Patient with Prefibrotic Primary Myelofibrosis: A Case Report
by: Mahendra Atlani, et al.
Published: (2021-01-01)